BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 27743816)

  • 1. Neoatherosclerosis causing occlusive in-stent restenosis: Impact of intracoronary imaging in the intensity of lipid-lowering therapy.
    Martí D; López E; Álvarez S; Palazuelos J; Rada I; Alfonso F
    Cardiovasc Revasc Med; 2016 Dec; 17(8):584-585. PubMed ID: 27743816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
    Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
    Komukai K; Bernelli C; Sirbu V; Guagliumi G
    EuroIntervention; 2015 Nov; 11(7):e1-2. PubMed ID: 26603864
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography.
    Ellert J; Antonsen L; Jensen LO
    Cardiovasc Revasc Med; 2017; 18(3):207-211. PubMed ID: 27650886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal course of vessel healing and neoatherosclerosis after DES implantation.
    Kozuki A; Shinke T; Otake H; Shite J; Nakagawa M; Nagoshi R; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hirata KI
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1121-1123. PubMed ID: 24135328
    [No Abstract]   [Full Text] [Related]  

  • 9. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early in-stent neoatherosclerosis assessed by optical coherence tomography.
    Vergara-Martel A; Pizzato PE; Dallan LAP; Pereira GTR; Richmond HCT; Attizzani GF; Jones MR
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1793-1794. PubMed ID: 31175526
    [No Abstract]   [Full Text] [Related]  

  • 11. Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
    Sherbet DP; Christopoulos G; Karatasakis A; Danek BA; Kotsia A; Navara R; Michael TT; Roesle M; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2016; 17(7):444-449. PubMed ID: 27133499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II).
    Teeuwen K; Van den Branden BJ; Rahel BM; Laarman GJ; Tijssen JG; Kelder JC; Slagboom T; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2013 Jun; 9(2):212-9. PubMed ID: 23392450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcified Neoatherosclerosis Causing "Undilatable" In-Stent Restenosis: Insights of Optical Coherence Tomography and Role of Rotational Atherectomy.
    Bastante T; Rivero F; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2039-2040. PubMed ID: 26738675
    [No Abstract]   [Full Text] [Related]  

  • 14. Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.
    Hu S; Wang C; Zhe C; Zhu Y; Yonetsu T; Jia H; Hou J; Zhang S; Jang IK; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):592-600. PubMed ID: 28318137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruptured neoatherosclerosis presenting as a large intrastent neointimal dissection.
    Rivero F; Cuesta J; Benedicto A; Bastante T; Alfonso F
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e169-70. PubMed ID: 25459046
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 19. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.